Skip to content
You are not logged in |Login  
     
Limit search to available items
Book Cover
book
BookBook

Title Big pharma and drug pricing / Pete Schauer, book editor.

Publication Info. New York : Greenhaven Publishing, 2018.
©2018

Copies

Location Call No. Status
 Bristol, Main Library - Non Fiction  338.436 BIG    Check Shelf
Edition First edition.
Description 208 pages ; 24 cm.
Series Opposing viewpoints series
Opposing viewpoints series (Unnumbered)
Bibliography Includes bibliographical references and index.
Contents Introduction -- Why are prescription drugs so expensive? -- The truth behind the high costs of prescription drugs / Julie Appleby -- Higher education plays an important role in the pharma industry / Annie Waldman -- Patent laws keep drug prices high / Matthew Rimmer -- Market exclusivity delays the availability of cheaper generic drugs / Zachary Brennan -- Drug prices are high for legitimate reasons / Michael Rosenblatt, MD -- Why don't insurance companies cover all prescription drugs? -- Government-protected monopolies drive drug prices higher / Sydney Lupkin -- Consumers are caught in the middle when the interests of drug companies and insurers conflict / Alison Kodjak -- Employers should use their power to cut drug prices / Robert Galvin, MD, Roger Longman -- Lowering drug prices may mean switching medications / Alison Kodjak -- "Medically necessary" drugs are increasing prices overall / Marcelle Arak and Sheila Tschinkel.
What are the ethics behind charging astronomical prices for prescription drugs? -- The ethics of pharmaceutical benefit management are blurry / Stephan L. Burton, Lauren Randel, Karen Titlow, and Ezekiel J. Emanuel -- Americans spend more on prescriptions than most other countries / Steve Morgan and Jae Kennedy -- Nothing stops drug companies from charging the highest market price / AARP -- Encouraging competition is the answer to affordable pharmaceuticals / Charles L. Hooper and David R. Henderson -- Prescription demand is why Americans pay so much for drugs / Valerie Paris -- Will we see legislative changes to the way drugs are priced? -- Government reforms can address consumer concerns / Rachel Sachs -- Big pharma has too much influence over politicians / Mike Ludwig -- Transparency bills are the key to lowering drug prices / Michael Ollove --tIt's time to rein in exorbitant pharmaceutical prices / Rafi Mohammed -- The government doesn't deserve the blame for high drug prices / David Blumenthal, M.D. and David Squires -- Pharma companies game the system to keep drugs expensive / Erin Fox.
Summary Americans pay among the highest prices for prescription drugs, thanks to government legislation and the powerful pharmaceutical lobbies. The effect has been disastrous, with many citizens obtaining cheaper medicine from Canada, and others forgoing it altogether at the risk of their health. These crippling prices are set by "big pharma," at the insistence of those who support free trade. Consumers call the pharmaceutical companies greedy and selfish, but these companies also enact change, through scientific research, curing of diseases, and community outreach. What is the answer to this complex issue? Readers will learn about the conflicts and potential solutions in this compelling volume.
Subject Drugs -- Prices -- United States.
Prescription pricing -- United States.
Pharmaceutical industry -- United States.
Drugs -- United States -- Cost control.
Drugs -- Cost control. (OCoLC)fst00898785
Drugs -- Prices. (OCoLC)fst00898879
Pharmaceutical industry. (OCoLC)fst01060129
Prescription pricing. (OCoLC)fst01075656
United States. (OCoLC)fst01204155
Added Author Schauer, Pete, editor.
ISBN 9781534501768 (hardcover)
1534501762 (hardcover)
9781534501829 (paperback)
1534501827 (paperback)
-->
Add a Review